HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Jerzy–Roch Nofer(University Hospital Münster), Bodo Levkau(Düsseldorf University Hospital), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Markus van der Giet(Charité - Universitätsmedizin Berlin), Iza Wolinska(University of Münster), Karin von Wnuck Lipinski(Heinrich Heine University Düsseldorf), Michael Schäfers(Blackberry (United States)), Markus Tölle(Charité - Universitätsmedizin Berlin), Hideo A. Baba(Essen University Hospital), Manfred Fobker(University of Münster), Walter Zidek(Charité - Universitätsmedizin Berlin), Uwe J.F. Tietge(Karolinska University Hospital), Axel Gödecke(Düsseldorf University Hospital), Burkhard Kleuser(Freie Universität Berlin), Gerd Assmann(University of Cambridge), Isao Ishii(Showa Pharmaceutical University)
Cited by 598
Related Papers
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k